BridgeMD
New treatment option for Systemic Lupus
Official title Biocollection of Rare Pediatric-onset of Autoimmune and Autoinflammatory Diseases
ClinicalTrials.gov ID: NCT06435468
What this study is testing
What is Blood sample for genetic analysis?
Blood sample for genetic analysis is an investigational medicine, being studied as a potential treatment for systemic lupus.
Plain-language explanation of the investigational treatment - it is being studied and is not an approved or proven therapy. The study team can confirm the details.
- What it's testing
- Rare diseases are defined as those that affect one person in 2,000, or around three million people in France. The majority of rare diseases are caused by genetics and tend to be severe when they begin in childhood.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 1 and older. Healthy volunteers may be eligible.
You may be able to join if
- Patients
- minor or adult patient of any age with a rare dysimmune disease characterized by autoimmunity or auto-inflammation or early lymphoproliferation...
- relative of a minor or adult patient with a rare dysimmune disease characterized by autoimmunity or auto-inflammation or early lymphoproliferation...
- weight greater than 5 kg
- Patient/parents/guardians who were informed of the study and signed the consent form.
You likely can't join if
- Patients \- people /Parents/guardians, refusing to participate in the study Healthy volunteer participants :
- active infection (viral, bacterial, parasitic)
- history of neoplasia (\< 5 years) or current neoplasia
- participants with a personal or family history of autoimmune disease
- immunocompromised participant (immune deficiency or transplant recipient)
- people/parents/guardians refusing to participate in the study
See the full eligibility criteria
- Patients
- minor or adult patient of any age with a rare dysimmune disease characterized by autoimmunity or auto-inflammation or early lymphoproliferation, having started in childhood (\<18 years), or syndromic or familial
- relative of a minor or adult patient with a rare dysimmune disease characterized by autoimmunity or auto-inflammation or early lymphoproliferation, having started in childhood (\<18 years of age) or syndromic or...
- weight greater than 5 kg
- Patient/parents/guardians who were informed of the study and signed the consent form.
- patient affiliated to a social security scheme Healthy volunteer participants
- minor or adult participants with no age restrictions
- weight over 5 kg
- Subject /Parents/guardians who were informed of the study and signed a consent form.
- Patient affiliated to a social security scheme
- Patients \- people /Parents/guardians, refusing to participate in the study Healthy volunteer participants :
- active infection (viral, bacterial, parasitic)
- history of neoplasia (\< 5 years) or current neoplasia
- participants with a personal or family history of autoimmune disease
- immunocompromised participant (immune deficiency or transplant recipient)
- people/parents/guardians refusing to participate in the study
- Adults under legal protection (guardianship, curatorship)
The study team makes the final eligibility decision.
Where it's taking place
- Bron, Bron, France
- Lille, Lille, France
- Nice, Nice, France
- Paris, Paris, France
- Saint-Etienne, Saint Etienne, France
- Grenoble, France
- Paris, France
- Rouen, France
- Strasbourg, France
- Villefranche-sur-Saône, France
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 1 year and older. Healthy volunteers may be eligible. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Bron, Bron, France; Lille, Lille, France; Nice, Nice, France; Paris, Paris, France; Saint-Etienne, Saint Etienne, France; Grenoble, France and 4 more location(s). Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.